Vibrotactile Coordinated Reset for Chronic Stroke
This study is testing a non-invasive therapy called Vibrotactile Coordinated Reset (vCR) for people who have had a stroke more than six months ago. vCR uses a device called the Vibrotactile (VT) Brain Glove to send gentle vibrations to your fingertips in a specific pattern. Researchers want to see if active vCR can improve motor ability (movement) compared to a sham (inactive) vCR. You might be able to join if you are 18-80 years old, have had a stroke, and meet other health criteria. Success will be measured by changes in your motor skills and quality of life related to upper body movement over several months. The study plans to enroll 20 participants.
- Study design
- This interventional study plans to enroll 20 participants and compares active Vibrotactile Coordinated Reset to a sham (inactive) version of the treatment.
- What's involved
- You would have clinical assessments at baseline, three months, four months, seven months, and eight months to measure motor recovery and upper extremity quality of life.
- Compensation
- Not stated in the trial record.
- Follow-up
- Participants will be followed for eight months after the baseline visit to assess changes in motor recovery and quality of life.
AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.
Vibrotactile Coordinated Reset for the Treatment of Chronic Stroke
At a glance
Conditions
NCT05490277
Where you'd take part
This study runs at 1 site. They're the same protocol — you choose where, and that choice sets who your contact draft is addressed to.
Stanford University
Stanford, Californiano site contact published
Sites open and close at different times, so the status above is per site — it can differ from the study's overall status.
Study leadership
- Peter A Tass, MD, PhD · PRINCIPAL_INVESTIGATOR · Stanford University
Who to contact
Opens a ready-to-send draft in your own email app — review before sending.
What this trial measures
- Fugl Meyer Assessment of Motor Recovery after Stroke change from baseline, 3 months, 4 months, 7months and 8 monthsThis clinical assessment will be done at baseline visit, three month visit, four month visit, seven month visit and eight month visit
The Fugl-Meyer Assessment (FMA) is a stroke-specific, performance-based impairment index. It is designed to assess motor functioning, balance, sensation and joint functioning in patients with post-stroke hemiplegia. It is applied clinically and in research to determine disease severity, describe motor recovery, and to plan and assess treatment. The scale is comprised of five domains and there are 155 items in total. Scoring is based on direct observation of performance. Scale items are scored on the basis of ability to complete the item using a 3-point ordinal scale where 0=cannot perform, 1=performs partially and 2=performs fully. The total possible scale score is 226.
- Neuro Quality of Life Upper Extremity Short Form test change from baseline, 3 months, 4 months, 7months and 8 monthsThis clinical assessment will be done at baseline visit, three month visit, four month visit, seven month visit and eight month visit
The Neuro quality of life upper extremity short form test measures the functionality of upper extremities. This is a self-report questionnaire that has a Likert scale from 1 to 5, with 5 indicating no difficulties and 1 indicating unable to do. Total possible points are out of 40, with a higher score indicating better upper extremity abilities.